Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Petros Pharmaceuticals Inc (PTPI)

Petros Pharmaceuticals Inc (PTPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics...

PTPI : 0.9406 (+10.30%)
Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company’s Novel Topical Investigational Treatment for Peyronie’s Disease Which Impacts More Than 1 in 10 Men in the US

Company Is Developing H-100 as Potentially the First FDA-Approved, Nanoparticle-Based Topical Treatment Designed to Provide Improved and Sustained Local...

PTPI : 0.9406 (+10.30%)
Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022

NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces...

PTPI : 0.9406 (+10.30%)
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV

LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's...

CHL.AX : 2.120 (-1.40%)
DCM : 25.60 (-1.35%)
DDDX : 0.0625 (+4.17%)
AAT.VN : 0.055 (unch)
AATGF : 0.0285 (-5.00%)
ASTR.VN : 0.200 (+14.29%)
AMI.VN : 0.345 (+1.47%)
AUUD : 1.0300 (+7.49%)
AYRO : 1.0400 (+4.00%)
BNXA.VN : 1.510 (-5.63%)
BNXAF : 1.2300 (-2.77%)
BICX : 2.5000 (+0.40%)
Petros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor Technology

Sensor Measures Oxygen Levels Within Specific Human Tissue, Potentially Allowing Biosensor Feedback of Erectile Device Therapy...

PTPI : 0.9406 (+10.30%)
Petros Pharmaceuticals Announces Positive Results of Over-the-Counter (OTC) Label Comprehension Study for Erectile Dysfunction Drug STENDRA (avanafil)

Clear Understanding of STENDRA OTC Label to be Key Element in OTC Development Program Company is Pursuing...

PTPI : 0.9406 (+10.30%)
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights

NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics...

PTPI : 0.9406 (+10.30%)
Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference

NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces...

PTPI : 0.9406 (+10.30%)
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand...

AZ.TO : 6.19 (unch)
AAZZF : 10.8545 (+0.13%)
ACST : 0.9466 (+2.63%)
ATNM : 5.63 (+2.36%)
ADCO.TO : 0.2700 (unch)
ADCOF : 0.2145 (+2.14%)
ALIM : 5.72 (-1.38%)
ACOGF : 0.5549 (+0.89%)
AMST : 0.5791 (-0.91%)
ANVS : 10.13 (+10.83%)
ANPC : 0.2909 (+6.56%)
ARC : 3.09 (+3.69%)
Petros Pharmaceuticals to Participate at Upcoming Benzinga Conference and Interview Show

/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief...

PTPI : 0.9406 (+10.30%)

Barchart Exclusives

Gold Moves Back Above The $1800 Level
Gold reached a new record high in early May as Russia invaded Ukraine. Since then, the price corrected, probing below the $1800 level on May 13th and May 16th. The gold futures market stopped correcting at the correct technical level and is now consolidating above the level that was the pivot point throughout most of 2021. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar